This article summarized the latest R&D progress of Betahistine Hydrochloride, the Mechanism of Action for Betahistine Hydrochloride, and the drug target R&D trends for Betahistine Hydrochloride.

CGRP, or calcitonin gene-related peptide, is a neuropeptide that plays a crucial role in the human body.

This article summarized the latest R&D progress of Artemether, the Mechanism of Action for Artemether, and the drug target R&D trends for Artemether.

Results from the Phase 2 clinical trial examining VGT-309 indicate that the trial drug could enhance surgeons' capacity to locate hard-to-spot and previously missed tumors in real-time, thereby potentially benefitting patient outcomes.

This article summarized the latest R&D progress of Zonisamide, the Mechanism of Action for Zonisamide, and the drug target R&D trends for Zonisamide.

CGAS (Cyclic GMP-AMP Synthase) is a crucial enzyme in the human body that plays a vital role in the innate immune response.

This article summarized the latest R&D progress of Zoledronic Acid, the Mechanism of Action for Zoledronic Acid, and the drug target R&D trends for Zoledronic Acid.

Lassen Therapeutics is developing novel antibody treatments for fibro-inflammatory diseases and cancer, focusing on the IL-11R receptor (LASN01) and interleukin-18 binding proteins.

This article summarized the latest R&D progress of Zaleplon, the Mechanism of Action for Zaleplon, and the drug target R&D trends for Zaleplon.

The CFTR protein is an ion channel mainly used to regulate the transepithelial movement of anions in mucus secretion tissues, thereby coordinating the balance of salt and fluid levels in mucus secretions.

This article summarized the latest R&D progress of Venetoclax, the Mechanism of Action for Venetoclax, and the drug target R&D trends for Venetoclax.

Positive high-level results from AstraZeneca's MANDARA Phase III study revealed that FASENRA(benralizumab)